Healthcare Value Capital, LLC - Q2 2020 holdings

$39.2 Million is the total value of Healthcare Value Capital, LLC's 19 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 26.9% .

 Value Shares↓ Weighting
GSK  GLAXOSMITHKLINE PLCsponsored adr$4,079,000
+7.7%
100,0000.0%10.41%
+63.4%
GILD  GILEAD SCIENCES INC$3,847,000
+2.9%
50,0000.0%9.82%
+56.2%
SPXU BuyPROSHARES TRultrapro short s$2,950,000
-18.5%
250,000
+66.7%
7.53%
+23.8%
MNLO BuyMENLO THERAPEUTICS INC$2,941,000
+29.1%
1,700,000
+100.0%
7.51%
+96.0%
TYME  TYME TECHNOLOGIES INC$2,893,000
+20.9%
2,175,0000.0%7.39%
+83.5%
CAH SellCARDINAL HEALTH INC$2,610,000
-27.4%
50,000
-33.3%
6.66%
+10.2%
ABBV SellABBVIE INC$2,455,000
-35.6%
25,000
-50.0%
6.27%
-2.2%
SPXU BuyPROSHARES TRcall$2,360,000
+30.5%
200,000
+166.7%
6.02%
+98.0%
WBA BuyWALGREENS BOOTS ALLIANCE INC$2,120,000
+85.3%
50,000
+100.0%
5.41%
+181.3%
JAZZ SellJAZZ PHARMACEUTICALS PLC$2,096,000
-29.9%
19,000
-36.7%
5.35%
+6.3%
CLVS  CLOVIS ONCOLOGY INC$1,688,000
+6.2%
250,0000.0%4.31%
+61.2%
CVS  CVS HEALTH CORP$1,624,000
+9.5%
25,0000.0%4.15%
+66.2%
MCK SellMCKESSON CORP$1,534,000
-54.6%
10,000
-60.0%
3.92%
-31.1%
ABC SellAMERISOURCEBERGEN CORP$1,512,000
-43.1%
15,000
-50.0%
3.86%
-13.6%
ATRS  ANTARES PHARMA INC$1,375,000
+16.5%
500,0000.0%3.51%
+76.9%
GNLN BuyGREENLANE HLDGS INCcl a$995,000
+157.1%
250,000
+11.1%
2.54%
+290.2%
VKTX  VIKING THERAPEUTICS INCcall$721,000
+54.1%
100,0000.0%1.84%
+133.9%
AMRN SellAMARIN CORP PLCcall$692,000
-13.5%
100,000
-50.0%
1.77%
+31.3%
CLVS  CLOVIS ONCOLOGY INCcall$675,000
+6.1%
100,0000.0%1.72%
+61.0%
ADMS ExitADAMAS PHARMACEUTICALS INCcall$0-200,000
-100.0%
-0.97%
BIS ExitPROSHARES TRcall$0-75,000
-100.0%
-1.78%
ALXN ExitALEXION PHARMACEUTICALS INC$0-30,000
-100.0%
-4.53%
SPXL ExitDIREXION SHS ETF TRcall$0-120,000
-100.0%
-5.26%
LH ExitLABORATORY CORP AMER HLDGS$0-25,000
-100.0%
-5.32%
AZN ExitASTRAZENECA PLCsponsored adr$0-75,000
-100.0%
-5.64%
GILD ExitGILEAD SCIENCES INCcall$0-50,000
-100.0%
-6.29%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GILEAD SCIENCES INC20Q3 202131.3%
GLAXOSMITHKLINE PLC20Q3 202116.1%
PFIZER INC19Q3 202117.9%
TYME TECHNOLOGIES INC17Q3 202140.3%
ASTRAZENECA PLC14Q3 202112.9%
QUEST DIAGNOSTICS INC14Q3 20169.5%
CRYOLIFE INC13Q1 20176.6%
ANTARES PHARMA INC13Q3 20216.7%
AMARIN CORP PLC13Q3 20214.9%
CYTOKINETICS INC13Q3 20161.7%

View Healthcare Value Capital, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Healthcare Value Capital, LLC Q2 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NOVELION THERAPEUTICS INC.September 20, 20191,400,0007.4%

View Healthcare Value Capital, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR2020-05-15
13F-HR2020-02-14
13F-HR2019-11-14
SC 13D/A2019-09-20

View Healthcare Value Capital, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (39165000.0 != 39167000.0)

Export Healthcare Value Capital, LLC's holdings